L471-0635 Screening compound: N-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]-3-[4-(piperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide

L471-0635 Screening compound: N-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]-3-[4-(piperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide
L471-0635 Screening compound: N-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]-3-[4-(piperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L471-0635
N-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]-3-[4-(piperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L471-0635

Molecular Formula

C24H26N6O2 (C24 H26 N6 O2)

Compound Name

N-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]-3-[4-(piperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide

IUPAC name

N-[2-(5-methyl-1H-13-benzodiazol-2-yl)ethyl]-3-[4-(piperidin-1-yl)phenyl]-124-oxadiazole-5-carboxamide

SMILES

Cc(cc1)cc2c1[nH]c(CCNC(c1nc(-c(cc3)ccc3N3CCCCC3)no1)=O)n2

InChI

InChI=1S/C24H26N6O2/c1-16-5-10-19-20(15-16)27-21(26-19)11-12-25-23(31)24-28-22(29-32-24)17-6-8-18(9-7-17)30-13-3-2-4-14-30/h5-10,15H,2-4,11-14H2,1H3,(H,25,31)(H,26,27)

InChI Key

DHAJWCQRJCDSFA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27255171

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.407

Distribution Coefficient, logD

4.406

Water Solubility, LogSw

-4.14

Polar Surface Area

79.905

Acid Dissociation Constant (pKa)

12.82

Base Dissociation Constant (pKb)

4.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

L471-0635 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

CNS Targets (44014 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L471-0635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L471-0635?
Check Price and Availability of L471-0635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L471-0635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L471-0635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L471-0635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L471-0635 available by request